nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—ABCB1—hematologic cancer	0.0962	1	CbGaD
Amprenavir—ABCC1—Idarubicin—hematologic cancer	0.0418	0.0616	CbGbCtD
Amprenavir—ABCC1—Daunorubicin—hematologic cancer	0.0296	0.0436	CbGbCtD
Amprenavir—CYP2B6—Thiotepa—hematologic cancer	0.0197	0.029	CbGbCtD
Amprenavir—ABCC1—Mitoxantrone—hematologic cancer	0.018	0.0265	CbGbCtD
Amprenavir—ABCC1—Epirubicin—hematologic cancer	0.0145	0.0214	CbGbCtD
Amprenavir—ABCC1—Irinotecan—hematologic cancer	0.0141	0.0208	CbGbCtD
Amprenavir—ABCC1—Vinblastine—hematologic cancer	0.0126	0.0185	CbGbCtD
Amprenavir—CYP2C9—Bexarotene—hematologic cancer	0.0125	0.0185	CbGbCtD
Amprenavir—ABCC1—Vincristine—hematologic cancer	0.0124	0.0182	CbGbCtD
Amprenavir—ABCB1—Lenalidomide—hematologic cancer	0.0122	0.0179	CbGbCtD
Amprenavir—ABCC1—Etoposide—hematologic cancer	0.0113	0.0167	CbGbCtD
Amprenavir—CYP2B6—Ifosfamide—hematologic cancer	0.0112	0.0164	CbGbCtD
Amprenavir—CYP2C8—Bortezomib—hematologic cancer	0.011	0.0162	CbGbCtD
Amprenavir—CYP3A5—Daunorubicin—hematologic cancer	0.011	0.0162	CbGbCtD
Amprenavir—CYP2D6—Lomustine—hematologic cancer	0.0107	0.0157	CbGbCtD
Amprenavir—CYP2C9—Idarubicin—hematologic cancer	0.0104	0.0153	CbGbCtD
Amprenavir—CYP3A5—Thalidomide—hematologic cancer	0.00998	0.0147	CbGbCtD
Amprenavir—CYP2B6—Nilotinib—hematologic cancer	0.00968	0.0143	CbGbCtD
Amprenavir—CYP3A5—Teniposide—hematologic cancer	0.00952	0.014	CbGbCtD
Amprenavir—CYP2D6—Idarubicin—hematologic cancer	0.0095	0.014	CbGbCtD
Amprenavir—CYP2C19—Bortezomib—hematologic cancer	0.00924	0.0136	CbGbCtD
Amprenavir—CYP3A5—Ifosfamide—hematologic cancer	0.00879	0.013	CbGbCtD
Amprenavir—CYP2C8—Ifosfamide—hematologic cancer	0.00845	0.0125	CbGbCtD
Amprenavir—CYP3A5—Imatinib—hematologic cancer	0.00839	0.0124	CbGbCtD
Amprenavir—CYP2D6—Hydroxyurea—hematologic cancer	0.00808	0.0119	CbGbCtD
Amprenavir—CYP2C19—Thalidomide—hematologic cancer	0.00805	0.0119	CbGbCtD
Amprenavir—ABCC1—Doxorubicin—hematologic cancer	0.00773	0.0114	CbGbCtD
Amprenavir—CYP2C9—Bortezomib—hematologic cancer	0.00768	0.0113	CbGbCtD
Amprenavir—CYP2C19—Teniposide—hematologic cancer	0.00768	0.0113	CbGbCtD
Amprenavir—ABCC1—Methotrexate—hematologic cancer	0.00748	0.011	CbGbCtD
Amprenavir—CYP2C8—Nilotinib—hematologic cancer	0.00733	0.0108	CbGbCtD
Amprenavir—CYP3A4—Bexarotene—hematologic cancer	0.00729	0.0107	CbGbCtD
Amprenavir—ABCB1—Daunorubicin—hematologic cancer	0.00713	0.0105	CbGbCtD
Amprenavir—CYP2C19—Ifosfamide—hematologic cancer	0.00709	0.0104	CbGbCtD
Amprenavir—CYP2D6—Bortezomib—hematologic cancer	0.00703	0.0104	CbGbCtD
Amprenavir—ABCB1—Alitretinoin—hematologic cancer	0.00699	0.0103	CbGbCtD
Amprenavir—CYP3A4—Lomustine—hematologic cancer	0.00678	0.00999	CbGbCtD
Amprenavir—CYP3A4—Busulfan—hematologic cancer	0.00678	0.00999	CbGbCtD
Amprenavir—CYP2C19—Imatinib—hematologic cancer	0.00677	0.00998	CbGbCtD
Amprenavir—CYP3A5—Dasatinib—hematologic cancer	0.00674	0.00994	CbGbCtD
Amprenavir—CYP2C9—Thalidomide—hematologic cancer	0.00669	0.00987	CbGbCtD
Amprenavir—CYP2B6—Irinotecan—hematologic cancer	0.00666	0.00981	CbGbCtD
Amprenavir—CYP2C9—Teniposide—hematologic cancer	0.00639	0.00941	CbGbCtD
Amprenavir—CYP3A4—Thiotepa—hematologic cancer	0.00604	0.0089	CbGbCtD
Amprenavir—CYP2C9—Ifosfamide—hematologic cancer	0.00589	0.00869	CbGbCtD
Amprenavir—CYP2C9—Imatinib—hematologic cancer	0.00563	0.0083	CbGbCtD
Amprenavir—ABCB1—Imatinib—hematologic cancer	0.00546	0.00805	CbGbCtD
Amprenavir—CYP2B6—Cisplatin—hematologic cancer	0.00543	0.008	CbGbCtD
Amprenavir—CYP3A5—Irinotecan—hematologic cancer	0.00524	0.00773	CbGbCtD
Amprenavir—CYP2D6—Imatinib—hematologic cancer	0.00515	0.00759	CbGbCtD
Amprenavir—CYP2C9—Nilotinib—hematologic cancer	0.00512	0.00754	CbGbCtD
Amprenavir—ABCB1—Nilotinib—hematologic cancer	0.00496	0.00732	CbGbCtD
Amprenavir—ABCB1—Vinorelbine—hematologic cancer	0.00492	0.00726	CbGbCtD
Amprenavir—CYP3A4—Methoxsalen—hematologic cancer	0.0047	0.00692	CbGbCtD
Amprenavir—CYP2D6—Nilotinib—hematologic cancer	0.00468	0.0069	CbGbCtD
Amprenavir—CYP2D6—Vinorelbine—hematologic cancer	0.00464	0.00684	CbGbCtD
Amprenavir—CYP3A5—Vincristine—hematologic cancer	0.00458	0.00676	CbGbCtD
Amprenavir—CYP3A4—Bortezomib—hematologic cancer	0.00447	0.00659	CbGbCtD
Amprenavir—CYP2C19—Prednisone—hematologic cancer	0.00446	0.00658	CbGbCtD
Amprenavir—ABCB1—Dasatinib—hematologic cancer	0.00439	0.00647	CbGbCtD
Amprenavir—CYP2B6—Dexamethasone—hematologic cancer	0.00438	0.00646	CbGbCtD
Amprenavir—ABCB1—Mitoxantrone—hematologic cancer	0.00433	0.00639	CbGbCtD
Amprenavir—CYP3A4—Daunorubicin—hematologic cancer	0.00427	0.0063	CbGbCtD
Amprenavir—CYP3A5—Etoposide—hematologic cancer	0.0042	0.00619	CbGbCtD
Amprenavir—CYP2C8—Etoposide—hematologic cancer	0.00404	0.00595	CbGbCtD
Amprenavir—ABCB1—Betamethasone—hematologic cancer	0.00386	0.00569	CbGbCtD
Amprenavir—ABCB1—Gemcitabine—hematologic cancer	0.00383	0.00564	CbGbCtD
Amprenavir—ABCB1—Prednisolone—hematologic cancer	0.00381	0.00562	CbGbCtD
Amprenavir—CYP3A4—Cytarabine—hematologic cancer	0.00377	0.00556	CbGbCtD
Amprenavir—CYP3A4—Teniposide—hematologic cancer	0.00371	0.00547	CbGbCtD
Amprenavir—CYP2B6—Doxorubicin—hematologic cancer	0.00364	0.00536	CbGbCtD
Amprenavir—ABCB1—Prednisone—hematologic cancer	0.0036	0.00531	CbGbCtD
Amprenavir—CYP3A5—Dexamethasone—hematologic cancer	0.00345	0.00509	CbGbCtD
Amprenavir—CYP3A4—Ifosfamide—hematologic cancer	0.00343	0.00505	CbGbCtD
Amprenavir—ABCB1—Irinotecan—hematologic cancer	0.00341	0.00503	CbGbCtD
Amprenavir—CYP2C8—Dexamethasone—hematologic cancer	0.00332	0.00489	CbGbCtD
Amprenavir—CYP3A4—Imatinib—hematologic cancer	0.00327	0.00482	CbGbCtD
Amprenavir—CYP3A4—Ruxolitinib—hematologic cancer	0.00308	0.00454	CbGbCtD
Amprenavir—ABCB1—Vinblastine—hematologic cancer	0.00303	0.00447	CbGbCtD
Amprenavir—ABCB1—Vincristine—hematologic cancer	0.00298	0.0044	CbGbCtD
Amprenavir—CYP3A4—Nilotinib—hematologic cancer	0.00297	0.00438	CbGbCtD
Amprenavir—CYP3A4—Vinorelbine—hematologic cancer	0.00295	0.00435	CbGbCtD
Amprenavir—CYP2C9—Cisplatin—hematologic cancer	0.00287	0.00423	CbGbCtD
Amprenavir—CYP2D6—Vinblastine—hematologic cancer	0.00286	0.00421	CbGbCtD
Amprenavir—CYP2C19—Dexamethasone—hematologic cancer	0.00279	0.00411	CbGbCtD
Amprenavir—ABCB1—Cisplatin—hematologic cancer	0.00278	0.0041	CbGbCtD
Amprenavir—ABCB1—Etoposide—hematologic cancer	0.00273	0.00403	CbGbCtD
Amprenavir—CYP3A4—Triamcinolone—hematologic cancer	0.0027	0.00398	CbGbCtD
Amprenavir—CYP3A4—Dasatinib—hematologic cancer	0.00263	0.00388	CbGbCtD
Amprenavir—CYP3A4—Mitoxantrone—hematologic cancer	0.0026	0.00383	CbGbCtD
Amprenavir—CYP2C9—Dexamethasone—hematologic cancer	0.00232	0.00341	CbGbCtD
Amprenavir—CYP3A4—Betamethasone—hematologic cancer	0.00231	0.00341	CbGbCtD
Amprenavir—CYP3A4—Prednisolone—hematologic cancer	0.00228	0.00337	CbGbCtD
Amprenavir—ABCB1—Dexamethasone—hematologic cancer	0.00225	0.00331	CbGbCtD
Amprenavir—CYP3A4—Prednisone—hematologic cancer	0.00216	0.00318	CbGbCtD
Amprenavir—CYP2D6—Dexamethasone—hematologic cancer	0.00212	0.00312	CbGbCtD
Amprenavir—CYP3A4—Irinotecan—hematologic cancer	0.00204	0.00301	CbGbCtD
Amprenavir—ABCB1—Doxorubicin—hematologic cancer	0.00186	0.00275	CbGbCtD
Amprenavir—CYP3A4—Vinblastine—hematologic cancer	0.00182	0.00268	CbGbCtD
Amprenavir—ABCB1—Methotrexate—hematologic cancer	0.00181	0.00266	CbGbCtD
Amprenavir—CYP3A4—Vincristine—hematologic cancer	0.00179	0.00263	CbGbCtD
Amprenavir—CYP2D6—Doxorubicin—hematologic cancer	0.00176	0.00259	CbGbCtD
Amprenavir—CYP3A4—Etoposide—hematologic cancer	0.00164	0.00241	CbGbCtD
Amprenavir—CYP3A4—Dexamethasone—hematologic cancer	0.00135	0.00198	CbGbCtD
Amprenavir—CYP3A4—Doxorubicin—hematologic cancer	0.00112	0.00165	CbGbCtD
Amprenavir—CYP2C19—hematopoietic system—hematologic cancer	0.000284	0.063	CbGeAlD
Amprenavir—CYP2C8—hematopoietic system—hematologic cancer	0.000248	0.055	CbGeAlD
Amprenavir—CYP3A5—hematopoietic system—hematologic cancer	0.000224	0.0497	CbGeAlD
Amprenavir—CYP2B6—hematopoietic system—hematologic cancer	0.000223	0.0494	CbGeAlD
Amprenavir—CYP2C9—hematopoietic system—hematologic cancer	0.00022	0.0489	CbGeAlD
Amprenavir—ABCC1—blood—hematologic cancer	0.000193	0.0428	CbGeAlD
Amprenavir—CYP2C19—blood—hematologic cancer	0.000188	0.0418	CbGeAlD
Amprenavir—ABCC1—lung—hematologic cancer	0.000169	0.0375	CbGeAlD
Amprenavir—CYP2B6—gonad—hematologic cancer	0.000169	0.0375	CbGeAlD
Amprenavir—CYP3A4—hematopoietic system—hematologic cancer	0.000168	0.0373	CbGeAlD
Amprenavir—CYP2D6—hematopoietic system—hematologic cancer	0.000165	0.0367	CbGeAlD
Amprenavir—CYP2C8—blood—hematologic cancer	0.000164	0.0365	CbGeAlD
Amprenavir—ABCC1—testis—hematologic cancer	0.00016	0.0354	CbGeAlD
Amprenavir—CYP3A5—blood—hematologic cancer	0.000148	0.0329	CbGeAlD
Amprenavir—CYP2B6—blood—hematologic cancer	0.000147	0.0327	CbGeAlD
Amprenavir—CYP2C9—blood—hematologic cancer	0.000146	0.0324	CbGeAlD
Amprenavir—CYP2C8—testis—hematologic cancer	0.000136	0.0302	CbGeAlD
Amprenavir—CYP3A5—lung—hematologic cancer	0.00013	0.0288	CbGeAlD
Amprenavir—CYP2B6—lung—hematologic cancer	0.000129	0.0287	CbGeAlD
Amprenavir—CYP2B6—testis—hematologic cancer	0.000122	0.0271	CbGeAlD
Amprenavir—ABCB1—hematopoietic system—hematologic cancer	0.000119	0.0264	CbGeAlD
Amprenavir—ABCC1—lymph node—hematologic cancer	0.000116	0.0257	CbGeAlD
Amprenavir—CYP3A4—blood—hematologic cancer	0.000111	0.0247	CbGeAlD
Amprenavir—CYP2D6—blood—hematologic cancer	0.00011	0.0243	CbGeAlD
Amprenavir—CYP2D6—testis—hematologic cancer	9.06e-05	0.0201	CbGeAlD
Amprenavir—ABCB1—gonad—hematologic cancer	9.05e-05	0.0201	CbGeAlD
Amprenavir—ABCB1—blood—hematologic cancer	7.88e-05	0.0175	CbGeAlD
Amprenavir—ABCB1—bone marrow—hematologic cancer	7.63e-05	0.0169	CbGeAlD
Amprenavir—ABCB1—lung—hematologic cancer	6.91e-05	0.0153	CbGeAlD
Amprenavir—ABCB1—testis—hematologic cancer	6.52e-05	0.0145	CbGeAlD
Amprenavir—Diarrhoea—Thalidomide—hematologic cancer	6.15e-05	0.000335	CcSEcCtD
Amprenavir—Asthenia—Alitretinoin—hematologic cancer	6.13e-05	0.000334	CcSEcCtD
Amprenavir—Rash—Vinorelbine—hematologic cancer	6.13e-05	0.000334	CcSEcCtD
Amprenavir—Dermatitis—Vinorelbine—hematologic cancer	6.13e-05	0.000333	CcSEcCtD
Amprenavir—Headache—Vinorelbine—hematologic cancer	6.09e-05	0.000332	CcSEcCtD
Amprenavir—Asthenia—Ifosfamide—hematologic cancer	6.06e-05	0.00033	CcSEcCtD
Amprenavir—Pruritus—Alitretinoin—hematologic cancer	6.05e-05	0.000329	CcSEcCtD
Amprenavir—Paraesthesia—Etoposide—hematologic cancer	5.99e-05	0.000326	CcSEcCtD
Amprenavir—Pruritus—Ifosfamide—hematologic cancer	5.98e-05	0.000325	CcSEcCtD
Amprenavir—Hyperglycaemia—Epirubicin—hematologic cancer	5.93e-05	0.000323	CcSEcCtD
Amprenavir—Hepatobiliary disease—Methotrexate—hematologic cancer	5.93e-05	0.000323	CcSEcCtD
Amprenavir—Nausea—Bortezomib—hematologic cancer	5.92e-05	0.000322	CcSEcCtD
Amprenavir—Asthenia—Vincristine—hematologic cancer	5.91e-05	0.000322	CcSEcCtD
Amprenavir—Paraesthesia—Prednisolone—hematologic cancer	5.91e-05	0.000322	CcSEcCtD
Amprenavir—Vomiting—Thiotepa—hematologic cancer	5.9e-05	0.000321	CcSEcCtD
Amprenavir—Diarrhoea—Carmustine—hematologic cancer	5.9e-05	0.000321	CcSEcCtD
Amprenavir—Mental disorder—Prednisone—hematologic cancer	5.9e-05	0.000321	CcSEcCtD
Amprenavir—Nausea—Bleomycin—hematologic cancer	5.87e-05	0.00032	CcSEcCtD
Amprenavir—Malnutrition—Prednisone—hematologic cancer	5.86e-05	0.000319	CcSEcCtD
Amprenavir—Rash—Thiotepa—hematologic cancer	5.86e-05	0.000319	CcSEcCtD
Amprenavir—Dermatitis—Thiotepa—hematologic cancer	5.85e-05	0.000318	CcSEcCtD
Amprenavir—Diarrhoea—Alitretinoin—hematologic cancer	5.85e-05	0.000318	CcSEcCtD
Amprenavir—Headache—Thiotepa—hematologic cancer	5.82e-05	0.000317	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Epirubicin—hematologic cancer	5.81e-05	0.000316	CcSEcCtD
Amprenavir—Decreased appetite—Etoposide—hematologic cancer	5.8e-05	0.000316	CcSEcCtD
Amprenavir—Diarrhoea—Ifosfamide—hematologic cancer	5.78e-05	0.000315	CcSEcCtD
Amprenavir—Nausea—Vinorelbine—hematologic cancer	5.78e-05	0.000314	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Etoposide—hematologic cancer	5.76e-05	0.000314	CcSEcCtD
Amprenavir—Asthenia—Mitoxantrone—hematologic cancer	5.75e-05	0.000313	CcSEcCtD
Amprenavir—Asthenia—Irinotecan—hematologic cancer	5.75e-05	0.000313	CcSEcCtD
Amprenavir—Fatigue—Etoposide—hematologic cancer	5.75e-05	0.000313	CcSEcCtD
Amprenavir—Myalgia—Dexamethasone—hematologic cancer	5.73e-05	0.000312	CcSEcCtD
Amprenavir—Myalgia—Betamethasone—hematologic cancer	5.73e-05	0.000312	CcSEcCtD
Amprenavir—Vomiting—Thalidomide—hematologic cancer	5.71e-05	0.000311	CcSEcCtD
Amprenavir—Neutropenia—Doxorubicin—hematologic cancer	5.69e-05	0.00031	CcSEcCtD
Amprenavir—Rash—Thalidomide—hematologic cancer	5.66e-05	0.000308	CcSEcCtD
Amprenavir—Discomfort—Betamethasone—hematologic cancer	5.66e-05	0.000308	CcSEcCtD
Amprenavir—Discomfort—Dexamethasone—hematologic cancer	5.66e-05	0.000308	CcSEcCtD
Amprenavir—Dermatitis—Thalidomide—hematologic cancer	5.66e-05	0.000308	CcSEcCtD
Amprenavir—Diarrhoea—Vincristine—hematologic cancer	5.63e-05	0.000307	CcSEcCtD
Amprenavir—Headache—Thalidomide—hematologic cancer	5.63e-05	0.000306	CcSEcCtD
Amprenavir—Asthenia—Gemcitabine—hematologic cancer	5.61e-05	0.000305	CcSEcCtD
Amprenavir—Hepatobiliary disease—Epirubicin—hematologic cancer	5.55e-05	0.000302	CcSEcCtD
Amprenavir—Pruritus—Gemcitabine—hematologic cancer	5.53e-05	0.000301	CcSEcCtD
Amprenavir—Nausea—Thiotepa—hematologic cancer	5.52e-05	0.0003	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	5.51e-05	0.0003	CcSEcCtD
Amprenavir—Hyperglycaemia—Doxorubicin—hematologic cancer	5.49e-05	0.000299	CcSEcCtD
Amprenavir—Diarrhoea—Mitoxantrone—hematologic cancer	5.49e-05	0.000299	CcSEcCtD
Amprenavir—Diarrhoea—Irinotecan—hematologic cancer	5.49e-05	0.000299	CcSEcCtD
Amprenavir—Vomiting—Carmustine—hematologic cancer	5.49e-05	0.000299	CcSEcCtD
Amprenavir—Gastrointestinal pain—Etoposide—hematologic cancer	5.46e-05	0.000297	CcSEcCtD
Amprenavir—Rash—Carmustine—hematologic cancer	5.44e-05	0.000296	CcSEcCtD
Amprenavir—Dermatitis—Carmustine—hematologic cancer	5.43e-05	0.000296	CcSEcCtD
Amprenavir—Vomiting—Alitretinoin—hematologic cancer	5.43e-05	0.000296	CcSEcCtD
Amprenavir—Paraesthesia—Triamcinolone—hematologic cancer	5.43e-05	0.000296	CcSEcCtD
Amprenavir—Headache—Carmustine—hematologic cancer	5.4e-05	0.000294	CcSEcCtD
Amprenavir—Rash—Alitretinoin—hematologic cancer	5.39e-05	0.000293	CcSEcCtD
Amprenavir—Nervous system disorder—Dexamethasone—hematologic cancer	5.38e-05	0.000293	CcSEcCtD
Amprenavir—Nervous system disorder—Betamethasone—hematologic cancer	5.38e-05	0.000293	CcSEcCtD
Amprenavir—Dermatitis—Alitretinoin—hematologic cancer	5.38e-05	0.000293	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	5.38e-05	0.000293	CcSEcCtD
Amprenavir—Vomiting—Ifosfamide—hematologic cancer	5.37e-05	0.000292	CcSEcCtD
Amprenavir—Headache—Alitretinoin—hematologic cancer	5.35e-05	0.000291	CcSEcCtD
Amprenavir—Angioedema—Prednisone—hematologic cancer	5.35e-05	0.000291	CcSEcCtD
Amprenavir—Diarrhoea—Gemcitabine—hematologic cancer	5.35e-05	0.000291	CcSEcCtD
Amprenavir—Nausea—Thalidomide—hematologic cancer	5.34e-05	0.00029	CcSEcCtD
Amprenavir—Rash—Ifosfamide—hematologic cancer	5.33e-05	0.00029	CcSEcCtD
Amprenavir—Dermatitis—Ifosfamide—hematologic cancer	5.32e-05	0.00029	CcSEcCtD
Amprenavir—Erythema multiforme—Methotrexate—hematologic cancer	5.32e-05	0.000289	CcSEcCtD
Amprenavir—Abdominal pain—Etoposide—hematologic cancer	5.27e-05	0.000287	CcSEcCtD
Amprenavir—Vomiting—Vincristine—hematologic cancer	5.24e-05	0.000285	CcSEcCtD
Amprenavir—Anorexia—Dexamethasone—hematologic cancer	5.23e-05	0.000285	CcSEcCtD
Amprenavir—Anorexia—Betamethasone—hematologic cancer	5.23e-05	0.000285	CcSEcCtD
Amprenavir—Asthenia—Cisplatin—hematologic cancer	5.22e-05	0.000284	CcSEcCtD
Amprenavir—Cardiac disorder—Methotrexate—hematologic cancer	5.22e-05	0.000284	CcSEcCtD
Amprenavir—Fatigue—Triamcinolone—hematologic cancer	5.22e-05	0.000284	CcSEcCtD
Amprenavir—Rash—Vincristine—hematologic cancer	5.19e-05	0.000283	CcSEcCtD
Amprenavir—Dermatitis—Vincristine—hematologic cancer	5.19e-05	0.000282	CcSEcCtD
Amprenavir—Connective tissue disorder—Epirubicin—hematologic cancer	5.17e-05	0.000282	CcSEcCtD
Amprenavir—Headache—Vincristine—hematologic cancer	5.16e-05	0.000281	CcSEcCtD
Amprenavir—Hepatobiliary disease—Doxorubicin—hematologic cancer	5.13e-05	0.000279	CcSEcCtD
Amprenavir—Nausea—Carmustine—hematologic cancer	5.12e-05	0.000279	CcSEcCtD
Amprenavir—Vomiting—Irinotecan—hematologic cancer	5.1e-05	0.000278	CcSEcCtD
Amprenavir—Vomiting—Mitoxantrone—hematologic cancer	5.1e-05	0.000278	CcSEcCtD
Amprenavir—Nausea—Alitretinoin—hematologic cancer	5.08e-05	0.000276	CcSEcCtD
Amprenavir—Rash—Mitoxantrone—hematologic cancer	5.06e-05	0.000275	CcSEcCtD
Amprenavir—Rash—Irinotecan—hematologic cancer	5.06e-05	0.000275	CcSEcCtD
Amprenavir—Dermatitis—Mitoxantrone—hematologic cancer	5.05e-05	0.000275	CcSEcCtD
Amprenavir—Dermatitis—Irinotecan—hematologic cancer	5.05e-05	0.000275	CcSEcCtD
Amprenavir—Headache—Irinotecan—hematologic cancer	5.02e-05	0.000273	CcSEcCtD
Amprenavir—Headache—Mitoxantrone—hematologic cancer	5.02e-05	0.000273	CcSEcCtD
Amprenavir—Nausea—Ifosfamide—hematologic cancer	5.02e-05	0.000273	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	5e-05	0.000272	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Betamethasone—hematologic cancer	5e-05	0.000272	CcSEcCtD
Amprenavir—Myalgia—Prednisone—hematologic cancer	4.99e-05	0.000272	CcSEcCtD
Amprenavir—Diarrhoea—Cisplatin—hematologic cancer	4.98e-05	0.000271	CcSEcCtD
Amprenavir—Erythema multiforme—Epirubicin—hematologic cancer	4.98e-05	0.000271	CcSEcCtD
Amprenavir—Vomiting—Gemcitabine—hematologic cancer	4.97e-05	0.00027	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	4.95e-05	0.00027	CcSEcCtD
Amprenavir—Paraesthesia—Dexamethasone—hematologic cancer	4.93e-05	0.000268	CcSEcCtD
Amprenavir—Paraesthesia—Betamethasone—hematologic cancer	4.93e-05	0.000268	CcSEcCtD
Amprenavir—Discomfort—Prednisone—hematologic cancer	4.93e-05	0.000268	CcSEcCtD
Amprenavir—Mental disorder—Methotrexate—hematologic cancer	4.93e-05	0.000268	CcSEcCtD
Amprenavir—Rash—Gemcitabine—hematologic cancer	4.93e-05	0.000268	CcSEcCtD
Amprenavir—Dermatitis—Gemcitabine—hematologic cancer	4.92e-05	0.000268	CcSEcCtD
Amprenavir—Malnutrition—Methotrexate—hematologic cancer	4.9e-05	0.000267	CcSEcCtD
Amprenavir—Headache—Gemcitabine—hematologic cancer	4.89e-05	0.000266	CcSEcCtD
Amprenavir—Nausea—Vincristine—hematologic cancer	4.89e-05	0.000266	CcSEcCtD
Amprenavir—Cardiac disorder—Epirubicin—hematologic cancer	4.88e-05	0.000266	CcSEcCtD
Amprenavir—Asthenia—Etoposide—hematologic cancer	4.79e-05	0.000261	CcSEcCtD
Amprenavir—Connective tissue disorder—Doxorubicin—hematologic cancer	4.79e-05	0.000261	CcSEcCtD
Amprenavir—Decreased appetite—Dexamethasone—hematologic cancer	4.77e-05	0.00026	CcSEcCtD
Amprenavir—Decreased appetite—Betamethasone—hematologic cancer	4.77e-05	0.00026	CcSEcCtD
Amprenavir—Nausea—Mitoxantrone—hematologic cancer	4.76e-05	0.000259	CcSEcCtD
Amprenavir—Nausea—Irinotecan—hematologic cancer	4.76e-05	0.000259	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Betamethasone—hematologic cancer	4.74e-05	0.000258	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Dexamethasone—hematologic cancer	4.74e-05	0.000258	CcSEcCtD
Amprenavir—Fatigue—Dexamethasone—hematologic cancer	4.73e-05	0.000258	CcSEcCtD
Amprenavir—Fatigue—Betamethasone—hematologic cancer	4.73e-05	0.000258	CcSEcCtD
Amprenavir—ABCB1—lymph node—hematologic cancer	4.73e-05	0.0105	CbGeAlD
Amprenavir—Pruritus—Etoposide—hematologic cancer	4.72e-05	0.000257	CcSEcCtD
Amprenavir—Nervous system disorder—Prednisone—hematologic cancer	4.69e-05	0.000255	CcSEcCtD
Amprenavir—Skin disorder—Prednisone—hematologic cancer	4.64e-05	0.000253	CcSEcCtD
Amprenavir—Nausea—Gemcitabine—hematologic cancer	4.64e-05	0.000253	CcSEcCtD
Amprenavir—Vomiting—Cisplatin—hematologic cancer	4.63e-05	0.000252	CcSEcCtD
Amprenavir—Mental disorder—Epirubicin—hematologic cancer	4.61e-05	0.000251	CcSEcCtD
Amprenavir—Erythema multiforme—Doxorubicin—hematologic cancer	4.6e-05	0.000251	CcSEcCtD
Amprenavir—Rash—Cisplatin—hematologic cancer	4.59e-05	0.00025	CcSEcCtD
Amprenavir—Dermatitis—Cisplatin—hematologic cancer	4.59e-05	0.00025	CcSEcCtD
Amprenavir—Malnutrition—Epirubicin—hematologic cancer	4.58e-05	0.000249	CcSEcCtD
Amprenavir—Diarrhoea—Etoposide—hematologic cancer	4.56e-05	0.000248	CcSEcCtD
Amprenavir—Anorexia—Prednisone—hematologic cancer	4.56e-05	0.000248	CcSEcCtD
Amprenavir—Cardiac disorder—Doxorubicin—hematologic cancer	4.52e-05	0.000246	CcSEcCtD
Amprenavir—Flatulence—Epirubicin—hematologic cancer	4.51e-05	0.000246	CcSEcCtD
Amprenavir—Gastrointestinal pain—Betamethasone—hematologic cancer	4.49e-05	0.000244	CcSEcCtD
Amprenavir—Gastrointestinal pain—Dexamethasone—hematologic cancer	4.49e-05	0.000244	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Prednisone—hematologic cancer	4.36e-05	0.000237	CcSEcCtD
Amprenavir—Asthenia—Triamcinolone—hematologic cancer	4.34e-05	0.000236	CcSEcCtD
Amprenavir—Abdominal pain—Betamethasone—hematologic cancer	4.34e-05	0.000236	CcSEcCtD
Amprenavir—Abdominal pain—Dexamethasone—hematologic cancer	4.34e-05	0.000236	CcSEcCtD
Amprenavir—Nausea—Cisplatin—hematologic cancer	4.33e-05	0.000235	CcSEcCtD
Amprenavir—Paraesthesia—Prednisone—hematologic cancer	4.29e-05	0.000234	CcSEcCtD
Amprenavir—Pruritus—Triamcinolone—hematologic cancer	4.28e-05	0.000233	CcSEcCtD
Amprenavir—Mental disorder—Doxorubicin—hematologic cancer	4.27e-05	0.000232	CcSEcCtD
Amprenavir—Vomiting—Etoposide—hematologic cancer	4.24e-05	0.000231	CcSEcCtD
Amprenavir—Malnutrition—Doxorubicin—hematologic cancer	4.24e-05	0.000231	CcSEcCtD
Amprenavir—Rash—Etoposide—hematologic cancer	4.21e-05	0.000229	CcSEcCtD
Amprenavir—Dermatitis—Etoposide—hematologic cancer	4.2e-05	0.000229	CcSEcCtD
Amprenavir—Headache—Etoposide—hematologic cancer	4.18e-05	0.000227	CcSEcCtD
Amprenavir—Flatulence—Doxorubicin—hematologic cancer	4.18e-05	0.000227	CcSEcCtD
Amprenavir—Myalgia—Methotrexate—hematologic cancer	4.17e-05	0.000227	CcSEcCtD
Amprenavir—Decreased appetite—Prednisone—hematologic cancer	4.16e-05	0.000226	CcSEcCtD
Amprenavir—Rash—Prednisolone—hematologic cancer	4.15e-05	0.000226	CcSEcCtD
Amprenavir—Dermatitis—Prednisolone—hematologic cancer	4.14e-05	0.000226	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	4.14e-05	0.000225	CcSEcCtD
Amprenavir—Fatigue—Prednisone—hematologic cancer	4.12e-05	0.000224	CcSEcCtD
Amprenavir—Headache—Prednisolone—hematologic cancer	4.12e-05	0.000224	CcSEcCtD
Amprenavir—Discomfort—Methotrexate—hematologic cancer	4.12e-05	0.000224	CcSEcCtD
Amprenavir—Nausea—Etoposide—hematologic cancer	3.96e-05	0.000216	CcSEcCtD
Amprenavir—Asthenia—Dexamethasone—hematologic cancer	3.94e-05	0.000214	CcSEcCtD
Amprenavir—Asthenia—Betamethasone—hematologic cancer	3.94e-05	0.000214	CcSEcCtD
Amprenavir—Nervous system disorder—Methotrexate—hematologic cancer	3.92e-05	0.000213	CcSEcCtD
Amprenavir—Gastrointestinal pain—Prednisone—hematologic cancer	3.91e-05	0.000213	CcSEcCtD
Amprenavir—Nausea—Prednisolone—hematologic cancer	3.91e-05	0.000213	CcSEcCtD
Amprenavir—Myalgia—Epirubicin—hematologic cancer	3.9e-05	0.000212	CcSEcCtD
Amprenavir—Pruritus—Betamethasone—hematologic cancer	3.88e-05	0.000211	CcSEcCtD
Amprenavir—Pruritus—Dexamethasone—hematologic cancer	3.88e-05	0.000211	CcSEcCtD
Amprenavir—Skin disorder—Methotrexate—hematologic cancer	3.88e-05	0.000211	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.87e-05	0.000211	CcSEcCtD
Amprenavir—Discomfort—Epirubicin—hematologic cancer	3.85e-05	0.00021	CcSEcCtD
Amprenavir—Vomiting—Triamcinolone—hematologic cancer	3.85e-05	0.000209	CcSEcCtD
Amprenavir—Rash—Triamcinolone—hematologic cancer	3.82e-05	0.000208	CcSEcCtD
Amprenavir—Dermatitis—Triamcinolone—hematologic cancer	3.81e-05	0.000207	CcSEcCtD
Amprenavir—Anorexia—Methotrexate—hematologic cancer	3.81e-05	0.000207	CcSEcCtD
Amprenavir—Headache—Triamcinolone—hematologic cancer	3.79e-05	0.000206	CcSEcCtD
Amprenavir—Abdominal pain—Prednisone—hematologic cancer	3.78e-05	0.000206	CcSEcCtD
Amprenavir—Diarrhoea—Dexamethasone—hematologic cancer	3.76e-05	0.000204	CcSEcCtD
Amprenavir—Diarrhoea—Betamethasone—hematologic cancer	3.76e-05	0.000204	CcSEcCtD
Amprenavir—Nervous system disorder—Epirubicin—hematologic cancer	3.67e-05	0.0002	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.64e-05	0.000198	CcSEcCtD
Amprenavir—Skin disorder—Epirubicin—hematologic cancer	3.63e-05	0.000198	CcSEcCtD
Amprenavir—Myalgia—Doxorubicin—hematologic cancer	3.61e-05	0.000196	CcSEcCtD
Amprenavir—Nausea—Triamcinolone—hematologic cancer	3.59e-05	0.000196	CcSEcCtD
Amprenavir—Paraesthesia—Methotrexate—hematologic cancer	3.59e-05	0.000195	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	3.58e-05	0.000195	CcSEcCtD
Amprenavir—Discomfort—Doxorubicin—hematologic cancer	3.57e-05	0.000194	CcSEcCtD
Amprenavir—Anorexia—Epirubicin—hematologic cancer	3.56e-05	0.000194	CcSEcCtD
Amprenavir—Vomiting—Dexamethasone—hematologic cancer	3.49e-05	0.00019	CcSEcCtD
Amprenavir—Vomiting—Betamethasone—hematologic cancer	3.49e-05	0.00019	CcSEcCtD
Amprenavir—Decreased appetite—Methotrexate—hematologic cancer	3.47e-05	0.000189	CcSEcCtD
Amprenavir—Rash—Betamethasone—hematologic cancer	3.46e-05	0.000188	CcSEcCtD
Amprenavir—Rash—Dexamethasone—hematologic cancer	3.46e-05	0.000188	CcSEcCtD
Amprenavir—Dermatitis—Betamethasone—hematologic cancer	3.46e-05	0.000188	CcSEcCtD
Amprenavir—Dermatitis—Dexamethasone—hematologic cancer	3.46e-05	0.000188	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.45e-05	0.000188	CcSEcCtD
Amprenavir—Fatigue—Methotrexate—hematologic cancer	3.45e-05	0.000188	CcSEcCtD
Amprenavir—Headache—Dexamethasone—hematologic cancer	3.44e-05	0.000187	CcSEcCtD
Amprenavir—Headache—Betamethasone—hematologic cancer	3.44e-05	0.000187	CcSEcCtD
Amprenavir—Asthenia—Prednisone—hematologic cancer	3.43e-05	0.000187	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.41e-05	0.000185	CcSEcCtD
Amprenavir—Nervous system disorder—Doxorubicin—hematologic cancer	3.39e-05	0.000185	CcSEcCtD
Amprenavir—Pruritus—Prednisone—hematologic cancer	3.38e-05	0.000184	CcSEcCtD
Amprenavir—Skin disorder—Doxorubicin—hematologic cancer	3.36e-05	0.000183	CcSEcCtD
Amprenavir—Paraesthesia—Epirubicin—hematologic cancer	3.36e-05	0.000183	CcSEcCtD
Amprenavir—Anorexia—Doxorubicin—hematologic cancer	3.3e-05	0.00018	CcSEcCtD
Amprenavir—Diarrhoea—Prednisone—hematologic cancer	3.27e-05	0.000178	CcSEcCtD
Amprenavir—Gastrointestinal pain—Methotrexate—hematologic cancer	3.27e-05	0.000178	CcSEcCtD
Amprenavir—Nausea—Dexamethasone—hematologic cancer	3.26e-05	0.000178	CcSEcCtD
Amprenavir—Nausea—Betamethasone—hematologic cancer	3.26e-05	0.000178	CcSEcCtD
Amprenavir—Decreased appetite—Epirubicin—hematologic cancer	3.25e-05	0.000177	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.23e-05	0.000176	CcSEcCtD
Amprenavir—Fatigue—Epirubicin—hematologic cancer	3.22e-05	0.000175	CcSEcCtD
Amprenavir—Abdominal pain—Methotrexate—hematologic cancer	3.16e-05	0.000172	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.15e-05	0.000172	CcSEcCtD
Amprenavir—Paraesthesia—Doxorubicin—hematologic cancer	3.11e-05	0.000169	CcSEcCtD
Amprenavir—Gastrointestinal pain—Epirubicin—hematologic cancer	3.06e-05	0.000166	CcSEcCtD
Amprenavir—Vomiting—Prednisone—hematologic cancer	3.04e-05	0.000165	CcSEcCtD
Amprenavir—Rash—Prednisone—hematologic cancer	3.01e-05	0.000164	CcSEcCtD
Amprenavir—Dermatitis—Prednisone—hematologic cancer	3.01e-05	0.000164	CcSEcCtD
Amprenavir—Decreased appetite—Doxorubicin—hematologic cancer	3.01e-05	0.000164	CcSEcCtD
Amprenavir—Headache—Prednisone—hematologic cancer	3e-05	0.000163	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.99e-05	0.000163	CcSEcCtD
Amprenavir—Fatigue—Doxorubicin—hematologic cancer	2.98e-05	0.000162	CcSEcCtD
Amprenavir—Abdominal pain—Epirubicin—hematologic cancer	2.96e-05	0.000161	CcSEcCtD
Amprenavir—Asthenia—Methotrexate—hematologic cancer	2.87e-05	0.000156	CcSEcCtD
Amprenavir—Nausea—Prednisone—hematologic cancer	2.84e-05	0.000155	CcSEcCtD
Amprenavir—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.83e-05	0.000154	CcSEcCtD
Amprenavir—Pruritus—Methotrexate—hematologic cancer	2.83e-05	0.000154	CcSEcCtD
Amprenavir—Abdominal pain—Doxorubicin—hematologic cancer	2.74e-05	0.000149	CcSEcCtD
Amprenavir—Diarrhoea—Methotrexate—hematologic cancer	2.73e-05	0.000149	CcSEcCtD
Amprenavir—Asthenia—Epirubicin—hematologic cancer	2.68e-05	0.000146	CcSEcCtD
Amprenavir—Pruritus—Epirubicin—hematologic cancer	2.65e-05	0.000144	CcSEcCtD
Amprenavir—Diarrhoea—Epirubicin—hematologic cancer	2.56e-05	0.000139	CcSEcCtD
Amprenavir—Vomiting—Methotrexate—hematologic cancer	2.54e-05	0.000138	CcSEcCtD
Amprenavir—Rash—Methotrexate—hematologic cancer	2.52e-05	0.000137	CcSEcCtD
Amprenavir—Dermatitis—Methotrexate—hematologic cancer	2.52e-05	0.000137	CcSEcCtD
Amprenavir—Headache—Methotrexate—hematologic cancer	2.5e-05	0.000136	CcSEcCtD
Amprenavir—Asthenia—Doxorubicin—hematologic cancer	2.48e-05	0.000135	CcSEcCtD
Amprenavir—Pruritus—Doxorubicin—hematologic cancer	2.45e-05	0.000133	CcSEcCtD
Amprenavir—Vomiting—Epirubicin—hematologic cancer	2.38e-05	0.000129	CcSEcCtD
Amprenavir—Nausea—Methotrexate—hematologic cancer	2.37e-05	0.000129	CcSEcCtD
Amprenavir—Diarrhoea—Doxorubicin—hematologic cancer	2.37e-05	0.000129	CcSEcCtD
Amprenavir—Rash—Epirubicin—hematologic cancer	2.36e-05	0.000128	CcSEcCtD
Amprenavir—Dermatitis—Epirubicin—hematologic cancer	2.36e-05	0.000128	CcSEcCtD
Amprenavir—Headache—Epirubicin—hematologic cancer	2.34e-05	0.000128	CcSEcCtD
Amprenavir—Nausea—Epirubicin—hematologic cancer	2.22e-05	0.000121	CcSEcCtD
Amprenavir—Vomiting—Doxorubicin—hematologic cancer	2.2e-05	0.00012	CcSEcCtD
Amprenavir—Rash—Doxorubicin—hematologic cancer	2.18e-05	0.000119	CcSEcCtD
Amprenavir—Dermatitis—Doxorubicin—hematologic cancer	2.18e-05	0.000119	CcSEcCtD
Amprenavir—Headache—Doxorubicin—hematologic cancer	2.17e-05	0.000118	CcSEcCtD
Amprenavir—Nausea—Doxorubicin—hematologic cancer	2.06e-05	0.000112	CcSEcCtD
Amprenavir—CYP3A5—Metabolism—CYCS—hematologic cancer	5.18e-06	0.000139	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—NUP98—hematologic cancer	5.17e-06	0.000139	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	5.15e-06	0.000138	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ENO2—hematologic cancer	5.13e-06	0.000138	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GSTT1—hematologic cancer	5.1e-06	0.000137	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ADCY7—hematologic cancer	5.07e-06	0.000136	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—NCOA3—hematologic cancer	5.07e-06	0.000136	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.03e-06	0.000135	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—NUP214—hematologic cancer	5.03e-06	0.000135	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ADCY7—hematologic cancer	5.02e-06	0.000135	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—NCOA3—hematologic cancer	5.02e-06	0.000135	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.02e-06	0.000135	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—FHL2—hematologic cancer	5e-06	0.000134	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—NUP214—hematologic cancer	4.99e-06	0.000134	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—SDC1—hematologic cancer	4.98e-06	0.000134	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GSTT1—hematologic cancer	4.97e-06	0.000134	CbGpPWpGaD
Amprenavir—ABCC1—Disease—FGF2—hematologic cancer	4.97e-06	0.000134	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PIK3CG—hematologic cancer	4.95e-06	0.000133	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.94e-06	0.000133	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ABCG2—hematologic cancer	4.93e-06	0.000132	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—MTR—hematologic cancer	4.93e-06	0.000132	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—AGRN—hematologic cancer	4.9e-06	0.000132	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PIK3R1—hematologic cancer	4.9e-06	0.000132	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ABCG2—hematologic cancer	4.89e-06	0.000131	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—MTR—hematologic cancer	4.89e-06	0.000131	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—SDC1—hematologic cancer	4.86e-06	0.000131	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ENO2—hematologic cancer	4.83e-06	0.00013	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	4.83e-06	0.00013	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ENO2—hematologic cancer	4.79e-06	0.000129	CbGpPWpGaD
Amprenavir—ABCC1—Disease—JAK2—hematologic cancer	4.76e-06	0.000128	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.76e-06	0.000128	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CD44—hematologic cancer	4.75e-06	0.000127	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—NQO1—hematologic cancer	4.75e-06	0.000127	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.7e-06	0.000126	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GSTT1—hematologic cancer	4.69e-06	0.000126	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GSTP1—hematologic cancer	4.68e-06	0.000126	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	4.66e-06	0.000125	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MDM2—hematologic cancer	4.65e-06	0.000125	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—IDH2—hematologic cancer	4.65e-06	0.000125	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—HMMR—hematologic cancer	4.65e-06	0.000125	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GSTT1—hematologic cancer	4.65e-06	0.000125	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.65e-06	0.000125	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—CREBBP—hematologic cancer	4.59e-06	0.000123	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—SDC1—hematologic cancer	4.58e-06	0.000123	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.58e-06	0.000123	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GSTP1—hematologic cancer	4.57e-06	0.000123	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—SDC1—hematologic cancer	4.54e-06	0.000122	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MTOR—hematologic cancer	4.53e-06	0.000122	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PIK3CB—hematologic cancer	4.53e-06	0.000122	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CD4—hematologic cancer	4.52e-06	0.000121	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.49e-06	0.000121	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CYCS—hematologic cancer	4.49e-06	0.000121	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	4.46e-06	0.00012	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ABCB1—hematologic cancer	4.43e-06	0.000119	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.37e-06	0.000117	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	4.36e-06	0.000117	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PIK3CD—hematologic cancer	4.35e-06	0.000117	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.34e-06	0.000117	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ABCB1—hematologic cancer	4.33e-06	0.000116	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GSTM1—hematologic cancer	4.3e-06	0.000115	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—NCOR1—hematologic cancer	4.3e-06	0.000115	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—ALB—hematologic cancer	4.29e-06	0.000115	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.28e-06	0.000115	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ACP5—hematologic cancer	4.25e-06	0.000114	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CA9—hematologic cancer	4.25e-06	0.000114	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CDKN1B—hematologic cancer	4.25e-06	0.000114	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—NQO1—hematologic cancer	4.24e-06	0.000114	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CD44—hematologic cancer	4.24e-06	0.000114	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—NCOR1—hematologic cancer	4.2e-06	0.000113	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GSTM1—hematologic cancer	4.2e-06	0.000113	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.2e-06	0.000113	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.15e-06	0.000111	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CD44—hematologic cancer	4.13e-06	0.000111	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—NQO1—hematologic cancer	4.13e-06	0.000111	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PIK3R1—hematologic cancer	4.11e-06	0.00011	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.1e-06	0.00011	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.02e-06	0.000108	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CYCS—hematologic cancer	4.01e-06	0.000108	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—IDH1—hematologic cancer	4e-06	0.000107	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	3.98e-06	0.000107	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GSTP1—hematologic cancer	3.96e-06	0.000106	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.95e-06	0.000106	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.95e-06	0.000106	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—TXN—hematologic cancer	3.95e-06	0.000106	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CDKN1A—hematologic cancer	3.92e-06	0.000105	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYCS—hematologic cancer	3.91e-06	0.000105	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PTEN—hematologic cancer	3.91e-06	0.000105	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CD44—hematologic cancer	3.9e-06	0.000105	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—NQO1—hematologic cancer	3.9e-06	0.000105	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—HSP90AA1—hematologic cancer	3.89e-06	0.000104	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.87e-06	0.000104	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CD44—hematologic cancer	3.86e-06	0.000104	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—NQO1—hematologic cancer	3.86e-06	0.000104	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.83e-06	0.000103	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—MTHFR—hematologic cancer	3.8e-06	0.000102	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PIK3CB—hematologic cancer	3.79e-06	0.000102	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.78e-06	0.000102	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ABCB1—hematologic cancer	3.75e-06	0.000101	CbGpPWpGaD
Amprenavir—ABCC1—Disease—EP300—hematologic cancer	3.73e-06	0.0001	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.72e-06	9.98e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—MTHFR—hematologic cancer	3.71e-06	9.97e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYCS—hematologic cancer	3.69e-06	9.9e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	3.66e-06	9.84e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYCS—hematologic cancer	3.65e-06	9.82e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GSTM1—hematologic cancer	3.64e-06	9.77e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—NCOR1—hematologic cancer	3.64e-06	9.77e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	3.63e-06	9.75e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—SRC—hematologic cancer	3.63e-06	9.74e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.62e-06	9.71e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.62e-06	9.71e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.58e-06	9.63e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GSTP1—hematologic cancer	3.53e-06	9.49e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.52e-06	9.46e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—STAT3—hematologic cancer	3.5e-06	9.39e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—NRAS—hematologic cancer	3.49e-06	9.37e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GSTP1—hematologic cancer	3.45e-06	9.26e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.42e-06	9.18e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NUP98—hematologic cancer	3.41e-06	9.16e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ABCB1—hematologic cancer	3.34e-06	8.98e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MAPK3—hematologic cancer	3.34e-06	8.97e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.31e-06	8.9e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.31e-06	8.9e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NUP214—hematologic cancer	3.29e-06	8.83e-05	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PTEN—hematologic cancer	3.27e-06	8.8e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.27e-06	8.78e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MYC—hematologic cancer	3.25e-06	8.73e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GSTP1—hematologic cancer	3.25e-06	8.73e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GSTM1—hematologic cancer	3.25e-06	8.72e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—NCOR1—hematologic cancer	3.25e-06	8.72e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—TGFB1—hematologic cancer	3.24e-06	8.71e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—MTR—hematologic cancer	3.22e-06	8.65e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.22e-06	8.65e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GSTP1—hematologic cancer	3.22e-06	8.65e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—MTHFR—hematologic cancer	3.21e-06	8.63e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PIK3CG—hematologic cancer	3.19e-06	8.57e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—NCOR1—hematologic cancer	3.17e-06	8.51e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GSTM1—hematologic cancer	3.17e-06	8.51e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ENO2—hematologic cancer	3.16e-06	8.49e-05	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—EP300—hematologic cancer	3.12e-06	8.39e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PIK3CG—hematologic cancer	3.12e-06	8.37e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.12e-06	8.37e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ABCB1—hematologic cancer	3.08e-06	8.26e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.06e-06	8.23e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ABCB1—hematologic cancer	3.05e-06	8.19e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—KRAS—hematologic cancer	3e-06	8.06e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SDC1—hematologic cancer	3e-06	8.05e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.99e-06	8.02e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.99e-06	8.02e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.96e-06	7.95e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.96e-06	7.95e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CREBBP—hematologic cancer	2.96e-06	7.94e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CREBBP—hematologic cancer	2.89e-06	7.76e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.87e-06	7.71e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.83e-06	7.61e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PIK3CD—hematologic cancer	2.8e-06	7.53e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—MTHFR—hematologic cancer	2.8e-06	7.52e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ALB—hematologic cancer	2.77e-06	7.44e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PIK3CA—hematologic cancer	2.76e-06	7.41e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PIK3CD—hematologic cancer	2.74e-06	7.36e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ALB—hematologic cancer	2.71e-06	7.27e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PIK3CG—hematologic cancer	2.7e-06	7.25e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PIK3R1—hematologic cancer	2.65e-06	7.11e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.64e-06	7.09e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.62e-06	7.03e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.59e-06	6.95e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—HRAS—hematologic cancer	2.55e-06	6.85e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CD44—hematologic cancer	2.55e-06	6.84e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NQO1—hematologic cancer	2.55e-06	6.84e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.53e-06	6.79e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.5e-06	6.73e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PIK3CB—hematologic cancer	2.44e-06	6.57e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—IL6—hematologic cancer	2.44e-06	6.56e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.41e-06	6.47e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYCS—hematologic cancer	2.41e-06	6.47e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.39e-06	6.43e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2.39e-06	6.42e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2.37e-06	6.38e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.35e-06	6.32e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ALB—hematologic cancer	2.34e-06	6.3e-05	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PIK3CA—hematologic cancer	2.31e-06	6.2e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.31e-06	6.19e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—AKT1—hematologic cancer	2.25e-06	6.05e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.24e-06	6.02e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.24e-06	6e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.22e-06	5.96e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.2e-06	5.9e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CREBBP—hematologic cancer	2.18e-06	5.86e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.12e-06	5.71e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.12e-06	5.69e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PTEN—hematologic cancer	2.11e-06	5.67e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ALB—hematologic cancer	2.09e-06	5.62e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.07e-06	5.56e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.07e-06	5.56e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PTEN—hematologic cancer	2.06e-06	5.55e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.06e-06	5.52e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ALB—hematologic cancer	2.04e-06	5.48e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.04e-06	5.47e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—EP300—hematologic cancer	2.01e-06	5.41e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.01e-06	5.4e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2e-06	5.37e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—EP300—hematologic cancer	1.97e-06	5.29e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.95e-06	5.25e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.95e-06	5.24e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.95e-06	5.24e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.95e-06	5.24e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.93e-06	5.19e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ALB—hematologic cancer	1.92e-06	5.17e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ALB—hematologic cancer	1.91e-06	5.12e-05	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—AKT1—hematologic cancer	1.89e-06	5.07e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.85e-06	4.96e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.84e-06	4.94e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.82e-06	4.9e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.8e-06	4.84e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PTEN—hematologic cancer	1.79e-06	4.8e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.73e-06	4.63e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—EP300—hematologic cancer	1.71e-06	4.58e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.7e-06	4.56e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.68e-06	4.52e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PTEN—hematologic cancer	1.6e-06	4.29e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PTEN—hematologic cancer	1.56e-06	4.18e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—EP300—hematologic cancer	1.52e-06	4.09e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.49e-06	4e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—EP300—hematologic cancer	1.49e-06	3.99e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PTEN—hematologic cancer	1.47e-06	3.94e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.46e-06	3.91e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PTEN—hematologic cancer	1.46e-06	3.91e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.45e-06	3.89e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—EP300—hematologic cancer	1.4e-06	3.76e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—EP300—hematologic cancer	1.39e-06	3.73e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.34e-06	3.61e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.27e-06	3.42e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.26e-06	3.39e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ALB—hematologic cancer	1.26e-06	3.38e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—AKT1—hematologic cancer	1.22e-06	3.27e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.2e-06	3.23e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—AKT1—hematologic cancer	1.19e-06	3.2e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.13e-06	3.02e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.11e-06	2.98e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.1e-06	2.95e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.04e-06	2.78e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—AKT1—hematologic cancer	1.03e-06	2.77e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.03e-06	2.76e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PTEN—hematologic cancer	9.6e-07	2.58e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—AKT1—hematologic cancer	9.2e-07	2.47e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—EP300—hematologic cancer	9.15e-07	2.46e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—AKT1—hematologic cancer	8.98e-07	2.41e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—AKT1—hematologic cancer	8.46e-07	2.27e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—AKT1—hematologic cancer	8.39e-07	2.25e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.77e-07	1.82e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—AKT1—hematologic cancer	5.53e-07	1.49e-05	CbGpPWpGaD
